๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The increase in lung cancer in Massachusetts

โœ Scribed by Herbert L. Lombard


Publisher
John Wiley and Sons
Year
1956
Tongue
English
Weight
294 KB
Volume
9
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


T accompanied by much speculation reg.irding the etiology of the disease. This paper indicate, the changes i n the male and female lung cancer death rates in hlassachusetts that have occLiri cd since 1906 and their apparent relationship to cigarette sinoking.

TRFNLE

In the construction of long-term trends, n u ~i ~c r o u s obstacles had to be overcome. Iri Massachusetts, prior to 1931, deaths caused by neoplasms of the lung, pleura, bronchus, and trachea were combined with a miscellaneous group of causes of death and classified as "cancer of other or unspecified organs." From 1931 to 1939, the fourth revision of the Manucil of tlrc Interircrtional List of Caiiscs of 1)etrtlr was used in Massachusetts. I n that edition, cancer of the respiratory system was divided into that of larynx, lung and pleura, and others. TIIC fifth revision of the Mnnual was first used in Massachusetts in 1940, and it separated cancer ol' the respiratory system into that ol larynx, trachea, bronchus, lung, pleura, nietliastinuin, and unspecified sites. T h e Sixth K(:ilisioii of the Iiiterntitional Lists of Diseases c i ~d C N U S ~S of L)cwtl/, first ~ised i n 1949, c o m bined the four respiratory sites untlcr two classifications: inalignant neoplasms of the trachea, bronchus, lung, and pleura, specified xnwtling to primary or secondary. Furthermore, the Sixtli I<evi.siora used a different iiicthotl ol c1;issilying the priority when multil'le causes of death were given. This resulted in a lower I-ec.orded death rate for cancer of inany sites, including that for the lung.

Since the data were not comparably classified, it was necessary to utilize several different procedures in order to coiripute trends for the period of 1906 to 1953. T h e original Massadiusctts death records for 1950 were classified by the fifth revision and compared with the data classified under the sixth revision. This mide possible the coniputation of correction From the Division o f C:anccr a n d Chronic Disease, hlassacliusctts I ~e p a r t m e n t of 1'ui)Iic Hcalth,


๐Ÿ“œ SIMILAR VOLUMES


Brachytherapy in lung cancer
โœ Gaspar, Laurie E. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 2 views

Brachytherapy, the direct application of a radioactive isotope into the tumor bed, delivers a high dose to the tumor as compared to the surrounding normal tissue. Interstitial brachytherapy, the placement of the isotope into a tumor bed where no lumen exists, has been described but is utilized infre

Lung cancer in Israel
โœ Joseph Rakower ๐Ÿ“‚ Article ๐Ÿ“… 1957 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 387 KB ๐Ÿ‘ 2 views
NEUROENDOCRINE DIFFERENTIATION IN LUNG C
โœ CAREY, FRANCIS A.; SAVE, VICKI E. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB ๐Ÿ‘ 2 views

The human lung has a resident population of neuroendocrine (NE) cells. These are characterised by the presence of neurosecretory granules and by a number of histochemical and immunocytochemical reactions. NE differentiation is a defining feature of classical and atypical carcinoid tumours and is see

Chemotherapeutic options in lung cancer
โœ Paul A. Bunn Jr.; Ariel F. Soriano ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 1 views

Lung carcinoma is the leading cause of cancer death in both men and women, accounting for 29% of all cancer deaths. There are no established screening measures, no established prevention agents, and current systemic therapies, such as cytotoxic chemotherapy, fail to cure metastatic disease. The cure

The applications of imaging in lung canc
โœ David G. Bragg ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 434 KB ๐Ÿ‘ 2 views